T cell vasoactive intestinal peptide receptor subtype expression differs between granulomas and spleen of schistosome-infected mice

Journal of Immunology

Volumn 157, Issue 1, 1996, Pages 265-270

  Metwali, Ahmed ^a,b   Elliott, David ^a   Blum, Arthur M ^a   Li, Jie ^a   Sandor, Matyas ^a   Weinstock, Joel V ^a,b  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RECEPTOR SUBTYPE; VASOACTIVE INTESTINAL POLYPEPTIDE RECEPTOR;

ANIMAL CELL; ARTICLE; ENZYME ACTIVATION; GENE EXPRESSION; GRANULOMA; GRANULOMATOUS INFLAMMATION; IMMUNE RESPONSE; INFLAMMATORY CELL; LIGAND BINDING; MOUSE; NEUROTRANSMITTER RELEASE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SCHISTOSOMA; SCHISTOSOMA MANSONI; T LYMPHOCYTE ACTIVATION;

ANIMALS; FEMALE; GRANULOMA; MICE; MICE, INBRED CBA; MOLECULAR SEQUENCE DATA; NEUROPEPTIDES; PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE; RECEPTORS, VASOACTIVE INTESTINAL PEPTIDE; RNA, MESSENGER; SCHISTOSOMIASIS MANSONI; SPLEEN; T-LYMPHOCYTES; TISSUE DISTRIBUTION;

EID: 0029891092     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Guerrero, J. M., J. Prieto, F. L. Elorza, R. Ramirez, and R. Goberna. 1981. Interactions of vasoactive intestinal peptides with human blood mononuclear cells. Mol. Cell. Endocrinol. 21:151.
2. Danek, A., M. S. O'Dorisio, T. M. O'Dorisio, and J. M. George. 1983. Specific binding sites for vasoactive intestinal polypeptide on nonadherent peripheral blood lymphocytes. J. Immunol. 131:1173.
3. Ottaway, C. A., C. Bernaerts, B. Chan, and G. R. Greenberg. 1983. Specific binding of vasoactive intestinal peptide to human circulating mononuclear cells. Can. J. Physiol. Pharmacol. 61:664.
4. Calvo, J. R., J. M. Guerrero, P. Molinero, R. Blasco, and R. Goberna. 1986. Interaction of vasoactive intestinal peptide (VIP) with human peripheral blood lymphocytes: specific binding and cyclic AMP production. Gen. Pharmacol. 17: 185.
5. Ottaway, C. A., T. E. Lay, and G. R. Greenberg. 1990. High affinity specific binding of vasoactive intestinal peptide to human circulating T cells, B cells and large granular lymphocytes. J. Neuroimmunol. 29:149.
6. Ottaway, C. A., and G. R. Greenberg. 1984. Interaction of vasoactive intestinal peptide with mouse lymphocytes: specific binding and the modulation of mitogen responses. J. Immunol. 132:417.
7. Finch, R. J., S. P. Sreedharan, and E. J. Goetzl. 1989. High-affinity receptors for vasoactive intestinal peptide on human myeloma cells. J. Immunol. 142:1977.
8. O'Dorisio, M. S., C. L. Wood, G. D. Wenger, and L. M. Vassalo. 1985. Cyclic amp-dependent protein kinase in molt 4b lymphoblasts: identification by photoaffinity labeling and activation in intact cells by vasoactive intestinal polypeptide (VIP) and peptide histidine isoleucine (PHI). J. Immunol. 134:4078.
9. O'Dorisio, M. S., B. T. Shannon, D. J. Fleshman, and L. B. Campolito. 1989. Identification of high affinity receptors for vasoactive intestinal peptide on human lymphocytes of B cell lineage. J. Immunol. 142:3533.
10. Robberecht, P., J. Abello, C. Damien, P. De Neef, E. Vervisch, R. Hooghe, and J. Christophe. 1989. Variable stimulation of adenylate cyclase activity by vasoactive intestinal-like peptides and β-adrenergic agonists in murine T cell lymphomas of immature, helper, and cytotoxic types, Immunobiology 179:422.
11. 3. Eur. J. Biochem. 183:263.
12. Segura, J. J., J. M. Guerrero, R. Goberna, and J. R. Calvo. 1991. Characterization of functional receptors for vasoactive intestinal peptide (VIP) in rat peritoneal macrophages. Regul. Pept. 33:133.
13. Calvo, J. R., M. L. Montilla, J. M. Guerrero, and J. J. Segura. 1994. Expression of VIP receptors in mouse peritoneal macrophages: functional and molecular characterization. J. Neuroimmunol. 50:85.
14. Sakakibara, H., K. Shima, and S. I. Said. 1994. Characterization of vasoactive intestinal peptide receptors on rat alveolar macrophages. Am. J. Physiol. 267: L256.
15. Ottaway, C. A. 1987. Selective effects of vasoactive intestinal peptide on the mitogenic response of murine T cells. Immunology 62:291.
16. Stanisz, A. M., D. Befus, and J. Bienenstock. 1986. Differential effects of vasoactive intestinal peptide, substance P, and somatostatin on immunoglobulin synthesis and proliferations by lymphocytes from Peyer's patches, mesenteric lymph nodes, and spleen. J. Immunol. 136:152.
17. Krco, C J., A. Gores, and V. L. W. Go. 1986. Gastrointestinal regulatory peptides modulate in vitro immune reactions of mouse lymphoid cells. Cell. Immunol. Immunopathol. 39:308.
18. Boudard, F., and M. Bastide. 1991. Inhibition of mouse T-cell proliferation by CGRP and VIP: effects of these neuropeptides on IL-2 production and cAMP synthesis. J. Neurosci. Res. 29:29.
19. Ottaway, C. A. 1984. In vitro alteration of receptors for vasoactive intestinal peptide changes the in vivo localization of mouse T cells. J. Exp. Med. 160:1054.
20. Boirivant, M., S. Fais, B. Annibale, D. Agostini, G. Delle Fave, and F. Pallone. 1994. Vasoactive intestinal polypeptide modulates the in vitro immunoglobulin A production by intestinal lamina propria lymphocytes. Gastroenterology 106:576.
21. Kimata, H., and M. Fujimoto. 1994. Vasoactive intestinal peptide specifically induces human IgA1 and IgA2 production. Eur. J. Immunol. 24:2262.
22. Johnston, J. A., D. D. Taub, A. R. Lloyd, K. Conlon, J. J. Oppenheim, and D. J. Kevlin. 1994. Human T lymphocyte chemotaxis and adhesion induced by vasoactive intestinal peptide. J. Immunol. 153:1762.
23. Johnson, A. R., and E. G. Erdös. 1973. Release of histamine from mast cells by vasoactive peptides. Proc. Soc. Exp. Biol. Med. 142:1252.
24. Rola-Pleszczynski, M., D. Bolduc, and S. St-Pierre. 1985. The effects of vasoactive intestinal peptide on human natural killer cell function. J. Immunol. 135: 2569.
25. Litwin, D. K., A. K. Wilson, and S. I. Said. 1992. Vasoactive intestinal polypeptide (VIP) inhibits rat alveolar macrophage phagocytosis and chemotaxis in vitro. Regul. Pept. 40:63.
26. Weinstock, J. V. 1992. The pathogenesis of granulomatous inflammation and organ injury in schistosomiasis: interactions between the schistosome ova and the host. Immunol. Invest. 21:455.
27. Weinstock, J. V., and A. M. Blum. 1990. Detection of vasoactive intestinal peptide and localization of its mRNA within granulomas of murine schistosomiasis. Cell. Immunol. 125:291.
28. Mathew, R. C., G. A. Cook, A. M. Blum, A. Metwali, R. Felman, and J. V. Weinstock. 1992. Vasoactive intestinal peptide stimulates T lymphocytes to release IL-5 in murine schistosomiasis mansoni infection. J Immunol. 148:3572.
29. Metwali, A., A. Blum, R. Mathew, M. Sandor, R. G. Lynch, and J. V. Weinstock. 1993. Modulation of T lymphocyte proliferation in mice infected with Schistosoma mansoni: VIP suppresses mitogen- and antigen-induced T cell proliferation possibly by inhibiting IL-2 production. Cell. Immunol. 149:11.
30. Weinstock, J. V., A. M. Blum, and S. Khetarpal. 1991. Granulomas in murine schistosomiasis mansoni contain vasoactive intestinal peptide-responsive lymphocytes. Cell. Immunol. 134:458.
31. Ishihara, T., R. Shigemoto, K. Mori, K. Takahashi, and S. Nagata. 1992. Functional expression and tissue distribution of a novel receptor for vasoactive intestinal polypeptide. Neuron 8:811.
32. Sreedharan, S. P., D. R. Patel, J.-X. Huang, and E. J. Goetzl. 1993. Cloning and functional expression of a human neuroendocrine vasoactive intestinal peptide receptor. Biochem. Biophys. Res. Commun. 193:546.
33. 2 receptor: molecular characterization of a DNA encoding a novel receptor for vasoactive intestinal peptide. Fed. Eur. Biochem. Soc. 334:3.
34. Peters, P. A., and K. S. Warren. 1969. A rapid method of infecting mice and other laboratory animals with Schistosoma mansoni: subcutaneous injection. J. Parasitol. 131:558.
35. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162: 156.
36. El Battari, A., P. Forget, F. Fouchier, and P. Pic. 1991. Effect of inhibiting N-glycosylation or oligosaccharide processing on vasoactive intestinal peptide receptor binding activity and structure. Biochem. J. 278:527.
37. Rens-Domiano, S., and T. Reisine. 1991. Structural analysis and functional role of carbohydrate component of somatostatin receptors. J. Biol. Chem. 266:20094.
38. Santer, R., Y. K. Leung, P. Alliet, E. Lebenthal, and P. C. Lee. 1990. The role of carbohydrate moieties of cholecystokinin receptors in cholecystokinin octapeptide binding: alteration of binding data by specific lectins. Biochim. Biophys. Acta 1051:78.
39. Chochola, J., C. Fabre, C. Bellan, J. Luis, S Bourgerie, B. Abadie, S. Champion, J. Marvaldi, and A. El Battari. 1993. Structural and functional analysis of the human vasoactive intestinal peptide receptor glycosylation. J. Biol. Chem. 268: 2312.
40. Robberecht, P., A. Cauvin, P. Gourlet, and J. Christophe. 1990. Heterogeneity of VIP receptors. Arch. Int. Pharmacodyn. 303:51.
41. Usdin, T. B., T. I. Bonner, and E. Mezey. 1994. Two receptors for vasoactive intestinal polypeptide with similar specificity and complementary distributions. Endocrinology 135:2662.
42. Svoboda, M., M. Tastenoy, J. Van Rampelbergh, J. F. Goossens, P. De Neef, M. Waelbroeck, and P. Robberecht. 1994. Molecular cloning and functional characterization of a human VIP receptor from SUP-T1 lymphoblasts. Biochem. Biophys. Res. Commun. 105:1617.
43. Inagaki, N., H. Yoshida, M. Mizuta, N. Mizuno, Y. Fujii, T. Gonoi, J-I. Miyazaki, and S. Seino. 1994. Cloning and functional characterization of a third pituitary adenylate cyclase-activating polypeptide receptor subtype expressed in insulin-secreting cells. Proc. Natl. Acad. Sci. USA 91:2679.